Resmetirom API Powder CAS 920509-32-6

Resmetirom API Powder stands as a cutting-edge active compound featuring outstanding target selectivity, and it marks a major advancement in managing adult non-alcoholic steatohepatitis. This compound acts on particular receptors within the liver, boasting remarkable tissue specificity. It works accurately on liver targets while barely interfering with receptors located in the heart, bones and other body parts, which greatly lowers the risks brought by non-specific effects across the body.

In terms of physiological regulation, it can efficiently modulate lipid metabolism inside the liver. It curbs the build-up and generation of redundant fats, speeds up the decomposition and turnover of fatty acids, and thereby cuts down fat deposits in the liver step by step. Additionally, it eases inflammatory reactions in the liver and holds back the development of pathological fibrosis. It also helps improve blood lipid profiles and creates a healthier state for the body's overall lipid metabolism.

In its physical form, Resmetirom API Powder is a white to off-white crystalline powder, with some formulations exhibiting a light yellow texture; its overall properties are stable. Resmetirom is primarily aimed at individuals with non-alcoholic steatohepatitis accompanied by mild to moderate liver fibrosis. It is designed to be used in conjunction with a healthy diet and a regular lifestyle of rest and exercise. It is also suitable for individuals with related conditions such as obesity, metabolic abnormalities, and blood sugar fluctuations.